iRex IVs — Credit Rating and Financial Key Figures

iRex IVs (CVR number: 37791121) is a company from AARHUS. The company reported a net sales of 0 mDKK in 2017. The operating profit percentage was poor at -182.9 % (EBIT: -0.1 mDKK), while net earnings were -69.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -114.4 %, which can be considered poor and Return on Equity (ROE) was -114.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 0 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. iRex IVs's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.